
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're navigating through a myriad of transformative advancements reshaping the industry. From artificial intelligence-driven research breakthroughs to strategic acquisitions in emerging therapeutic areas, these developments are setting new benchmarks in drug discovery and patient care. **Strategic Acquisitions and Expansions:** Samsung Biologics' recent ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily

AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily

Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily

Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily
Free AI-powered recaps of Pharma and BioTech Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.